Hangzhou Biotest Biotech Co Ltd (688767) — Net Asset Quality Index
Hangzhou Biotest Biotech Co Ltd (688767) has a Net Asset Quality Index of 95.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.49 Billion minus total liabilities of CN¥121.73 Million yields net assets of CN¥2.36 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Hangzhou Biotest Biotech Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hangzhou Biotest Biotech Co Ltd Net Asset Quality Index Over Time (2017–2025)
This chart shows how Hangzhou Biotest Biotech Co Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the index stands at 95.1%, representing net assets of CN¥2.36 Billion against total assets of CN¥2.49 Billion CNY. Explore Hangzhou Biotest Biotech Co Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Hangzhou Biotest Biotech Co Ltd (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Hangzhou Biotest Biotech Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Hangzhou Biotest Biotech Co Ltd market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.4% | CN¥2.37 Billion | CN¥2.54 Billion | CN¥168.17 Million | ▲ +0.7 pp |
| 2024 | 92.7% | CN¥2.41 Billion | CN¥2.60 Billion | CN¥189.79 Million | ▼ -1.1 pp |
| 2023 | 93.8% | CN¥2.42 Billion | CN¥2.58 Billion | CN¥158.82 Million | ▲ +0.7 pp |
| 2022 | 93.1% | CN¥2.56 Billion | CN¥2.75 Billion | CN¥188.92 Million | ▲ +6.4 pp |
| 2021 | 86.7% | CN¥2.11 Billion | CN¥2.43 Billion | CN¥323.36 Million | ▲ +16.8 pp |
| 2020 | 69.9% | CN¥443.02 Million | CN¥633.92 Million | CN¥190.89 Million | ▲ +10.0 pp |
| 2019 | 59.8% | CN¥125.95 Million | CN¥210.44 Million | CN¥84.50 Million | ▼ -3.6 pp |
| 2018 | 63.5% | CN¥98.15 Million | CN¥154.63 Million | CN¥56.48 Million | ▲ +1.0 pp |
| 2017 | 62.4% | CN¥79.63 Million | CN¥127.52 Million | CN¥47.88 Million | — |